NCT00599547

Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients

Allogeneic Stem Cell Transplantation After Dose-reduced Intensity Conditioning Regimen for Patients With Myelofibrosis With Myeloid Metaplasia (MMM): A Phase II-study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 106 (actual)
• Sponsor: Universitätsklinikum Hamburg-Eppendorf · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether a reduced intensity conditioning regimen followed by allogeneic stem cell transplantation is a feasible and effective treatment for patients with primary myelofibrosis.

Detailed description

The purpose of this study is to determine whether a reduced intensity conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors is a feasible and effective treatment for patients with primary myelofibrosis.

Conditions

• Myelofibrosis

Interventions

Type	Name	Description
PROCEDURE	Allogeneic Stem Cell Transplantation	Allogeneic Stem Cell Transplantation after dose-reduced Conditioning for Myelofibrosis Patients

Timeline

• Start date: 2002-11-01
• Primary completion: 2009-08-01
• Completion: 2009-12-01
• First posted: 2008-01-23
• Last updated: 2016-01-14

Locations

1 site across 1 country: Germany